About: Nexsen Limited operates as a nanobiotechnology company that develops proprietary biosensing platforms for rapid, high-precision point-of-care (POC) medical diagnostics and point-of-use sensing for veterinary, agricultural, and biosecurity applications. The company offers Group B Streptococcus (GBS) rapid sensor, a diagnostic for the detection of human GBS in expectant mothers; kidney diseases, a POC tests for the screening, detection, and ongoing monitoring of various subsets of acute kidney injury and chronic kidney disease; bovine mastitis, a farm diagnostic to detect mastitis early which helps farmers; biosecurity pathogen tests, a portable sensor for frontline detection of invasive pests and pathogens -built for customs officers, farmers, and quarantine zones. The company was incorporated in 2021 and is based in Sydney, Australia.
Sector: Healthcare
Industry: Biotechnology
Latest price: A$0.17 (-8.33%)
NXN ASX Nexsen Limited
Nexsen Limited share price
NXN price activity
Last Price
$0.170
Change (24hr)
-0.02 AUD (-8.33%)
Volume
15.70K
Volume (4w avg)
-
Open
$0.19
Day Range
$0.17 - $0.19
Previous Close
$0.18
Last Trade
17 Sep, 5:15 am GMT+0
Delayed
17 Sep, 5:15 am GMT+0
NXN price performance
Delayed
17 Sep, 5:15 am GMT+0
NXN Market Signals